Elena L. Savlevich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elena L. Savlevich has a total of 269 co-authors. Here are the top co-authors by number of shared publications:
- Oksana Mikhaylovna Kurbacheva
National Research Center — Institute of Immunology Federal Medical-Biological Agency
13 shared publications - Viktor I. Egorov
State-Financed Health Institution of Moscow Region Moscow Regional Scientific and Research Clinical Institute named after M.F. Vladimirskiy, Moscow, Russia
11 shared publications - E. S. Mitrofanova
Federal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies of the Federal Medical-Biological Agency
8 shared publications - Aleksandr Vladimirovich Zurochka
Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences; South Ural State University (National Research University)
7 shared publications - Andrey Nikolaevich Gerasimov
Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical and Biological Agency
6 shared publications - E. V. Lyubimova
Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences
6 shared publications
Latest Publications
- 5 June 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 169-175
A method for surgical treatment of nasal obstruction with limited resection of the edge of the pyriform aperture
Introduction . Despite the abundance of existing surgical methods, the problem of nasal obstruction treatment still remains unresolved due to inefficiency and postoperative recurrence. The failure of operations on the nasal septum and inferior turbinates encourages the search for other objects of surgical treatment. One such solution is the expansion of the piriform aperture. Aim. To develop a relatively simple to perform surgical treatment method for nasal obstruction, aimed at partial resection of the pyriform aperture rim and lateralization of the anterior portion of the inferior turbinate. Materials and methods . The goal is achieved through the proposed method (patent RU 2770270 C1) lateralization of the inferior turbinate with preliminary resection of the edge of the piriform aperture. Thus, 11 patients from 18 to 70 years old (7 men and 4 women) with chronic nasal obstruction were treated, 5 patients were operated on one side, 6 on both sides. The evaluation of the results of the surgical treatment was carried out by means of a questionnaire of patients on the NOSE (Nasal Obstruction Symptom Evaluation) scale before and 6 months after the operation. Results. The median score on the NOSE scale before surgical treatment is 90 (82.5–95). The median score on the NOSE scale 6 months after surgical treatment is 5 (0–10) (p < 0.01, Wilcoxon test). Conclusions . The proposed method of surgical treatment of nasal obstruction with limited resection of the edge of the pyriform aperture allows to obtain a good functional result and a 16-fold reduction in nasal obstruction scores according to the NOSE scale before and after surgery.
- 5 June 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 169-175
A method for surgical treatment of nasal obstruction with limited resection of the edge of the pyriform aperture
Introduction . Despite the abundance of existing surgical methods, the problem of nasal obstruction treatment still remains unresolved due to inefficiency and postoperative recurrence. The failure of operations on the nasal septum and inferior turbinates encourages the search for other objects of surgical treatment. One such solution is the expansion of the piriform aperture. Aim. To develop a relatively simple to perform surgical treatment method for nasal obstruction, aimed at partial resection of the pyriform aperture rim and lateralization of the anterior portion of the inferior turbinate. Materials and methods . The goal is achieved through the proposed method (patent RU 2770270 C1) lateralization of the inferior turbinate with preliminary resection of the edge of the piriform aperture. Thus, 11 patients from 18 to 70 years old (7 men and 4 women) with chronic nasal obstruction were treated, 5 patients were operated on one side, 6 on both sides. The evaluation of the results of the surgical treatment was carried out by means of a questionnaire of patients on the NOSE (Nasal Obstruction Symptom Evaluation) scale before and 6 months after the operation. Results. The median score on the NOSE scale before surgical treatment is 90 (82.5–95). The median score on the NOSE scale 6 months after surgical treatment is 5 (0–10) (p < 0.01, Wilcoxon test). Conclusions . The proposed method of surgical treatment of nasal obstruction with limited resection of the edge of the pyriform aperture allows to obtain a good functional result and a 16-fold reduction in nasal obstruction scores according to the NOSE scale before and after surgery.
- 1 January 2026
- Published by LLC Polyforum Group in Russian Otorhinolaryngology
- Vol. 25 (3)
Relationship between the parameters of the width of the pyriform aperture region
Although studies on surgical expansion of the pyriform aperture (PA) to relieve nasal obstruction are currently limited, available data show encouraging positive results. Objective. To determine the relationship between the maximum pyriform aperture width and other parameters of the pyriform aperture region width. Materials and methods. The study was based on identifying the relationship between the pyriform aperture width and the nasal cavity width between the origins of the inferior turbinate bony bases, as well as between the maximum pyriform aperture width and the pyriform aperture width in the axial plane of the inferior turbinate bases. These parameters were determined using cone-beam computed tomography data from 577 Caucasian individuals over 18 years of age (273 men and 304 women), divided into age groups according to World Health Organization (WHO) recommendations (18–44, 45–59, 60–74, and ≥75 years). Results and discussion. In all cases of correlation analysis, we obtained a strong (Pearson correlation coefficient ≥0.7) or very strong (Pearson correlation coefficient≥0.9), statistically significant (p < 0.001), positive correlation. The results obtained through correlation analysis show that in all cases, the width parameters under study are closely and directly (Pearson correlation coefficient ≥0.7) statistically significantly (p < 0.001) interrelated, and an increase in one directly increases the other. Conclusions. The study revealed a direct, strong or very strong correlation between the pyriform aperture width and the width of the nasal cavity between the origins of the inferior turbinate bony bases, as well as between the pyriform aperture width and the pyriform aperture width in the axial plane of the inferior turbinates. Based on the obtained study results, one of the measured parameters can be used for screening. If surgical enlargement of the pyriform aperture is likely, all the described parameters must be determined, since the type and volume of surgical intervention may depend on this. The obtained results should be used in the diagnostic algorithm if pyriform aperture stenosis is suspected.
- 1 January 2026
- Published by LLC Polyforum Group in Russian Otorhinolaryngology
- Vol. 25 (3)
Relationship between the parameters of the width of the pyriform aperture region
Although studies on surgical expansion of the pyriform aperture (PA) to relieve nasal obstruction are currently limited, available data show encouraging positive results. Objective. To determine the relationship between the maximum pyriform aperture width and other parameters of the pyriform aperture region width. Materials and methods. The study was based on identifying the relationship between the pyriform aperture width and the nasal cavity width between the origins of the inferior turbinate bony bases, as well as between the maximum pyriform aperture width and the pyriform aperture width in the axial plane of the inferior turbinate bases. These parameters were determined using cone-beam computed tomography data from 577 Caucasian individuals over 18 years of age (273 men and 304 women), divided into age groups according to World Health Organization (WHO) recommendations (18–44, 45–59, 60–74, and ≥75 years). Results and discussion. In all cases of correlation analysis, we obtained a strong (Pearson correlation coefficient ≥0.7) or very strong (Pearson correlation coefficient≥0.9), statistically significant (p < 0.001), positive correlation. The results obtained through correlation analysis show that in all cases, the width parameters under study are closely and directly (Pearson correlation coefficient ≥0.7) statistically significantly (p < 0.001) interrelated, and an increase in one directly increases the other. Conclusions. The study revealed a direct, strong or very strong correlation between the pyriform aperture width and the width of the nasal cavity between the origins of the inferior turbinate bony bases, as well as between the pyriform aperture width and the pyriform aperture width in the axial plane of the inferior turbinates. Based on the obtained study results, one of the measured parameters can be used for screening. If surgical enlargement of the pyriform aperture is likely, all the described parameters must be determined, since the type and volume of surgical intervention may depend on this. The obtained results should be used in the diagnostic algorithm if pyriform aperture stenosis is suspected.
- 20 November 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 18,p. 35-43
Modern possibilities of immunocorrection of inflammatory diseases of the oropharynx
One of the determining factors of the effectiveness of treatment of upper respiratory tract infections is the immunological reactivity of the mucous membranes. In this context, understanding the individual pathophysiological mechanisms of disease development and their clinical course, depending on the state of general and local immunity, will allow improving treatment tactics and achieving positive results at an earlier date. To substantiate the prospects of using a multicomponent phytonerating drug with a multidirectional effect in the treatment of inflammatory diseases of the upper respiratory tract with an emphasis on unique pharmacokinetic parameters and pharmacodynamic parameters. The analysis of literature sources highlighting topical issues of etiopathogenetic mechanisms of upper respiratory tract infections, clinical features, and the experience of researchers using phytoniringovyh drugs and their own observations. Databases of literature data were used: RSCI, Web of Science, PubMed, Google Scholar, Scopus, etc., according to keywords, ENT infections, upper respiratory tract infection, immunity, immunoglobulins, herbal medicines, phytotherapy, with a search depth of more than ten years. Among the reasons for seeking specialized otorhinolaryngological care, upper respiratory tract infections occupy a leading place. The key pathogens are RNA-containing viruses of four families and DNA-containing viruses of two families. The main effector of adaptive immunity, protection of the mucous membranes of the upper respiratory tract, is secretory class A immunoglobulin. There is a tendency to decrease the content of IFN-α and sIdA in the first days of the disease, which can be explained by a decrease in infectious protection, therefore, the search for drugs capable of affecting the local immune response is justified, and the medicinal phytopreparation Tonsilgon N. meets these requirements. The inclusion of the medicinal phytopreparation in the basic therapy of upper respiratory tract infections will achieve high results in relieving clinical symptoms by enhancing the local immune response of the oropharyngeal mucosa.
- 20 November 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 18,p. 35-43
Modern possibilities of immunocorrection of inflammatory diseases of the oropharynx
One of the determining factors of the effectiveness of treatment of upper respiratory tract infections is the immunological reactivity of the mucous membranes. In this context, understanding the individual pathophysiological mechanisms of disease development and their clinical course, depending on the state of general and local immunity, will allow improving treatment tactics and achieving positive results at an earlier date. To substantiate the prospects of using a multicomponent phytonerating drug with a multidirectional effect in the treatment of inflammatory diseases of the upper respiratory tract with an emphasis on unique pharmacokinetic parameters and pharmacodynamic parameters. The analysis of literature sources highlighting topical issues of etiopathogenetic mechanisms of upper respiratory tract infections, clinical features, and the experience of researchers using phytoniringovyh drugs and their own observations. Databases of literature data were used: RSCI, Web of Science, PubMed, Google Scholar, Scopus, etc., according to keywords, ENT infections, upper respiratory tract infection, immunity, immunoglobulins, herbal medicines, phytotherapy, with a search depth of more than ten years. Among the reasons for seeking specialized otorhinolaryngological care, upper respiratory tract infections occupy a leading place. The key pathogens are RNA-containing viruses of four families and DNA-containing viruses of two families. The main effector of adaptive immunity, protection of the mucous membranes of the upper respiratory tract, is secretory class A immunoglobulin. There is a tendency to decrease the content of IFN-α and sIdA in the first days of the disease, which can be explained by a decrease in infectious protection, therefore, the search for drugs capable of affecting the local immune response is justified, and the medicinal phytopreparation Tonsilgon N. meets these requirements. The inclusion of the medicinal phytopreparation in the basic therapy of upper respiratory tract infections will achieve high results in relieving clinical symptoms by enhancing the local immune response of the oropharyngeal mucosa.
- 16 October 2025
- Published by Bionika Media in Therapy
- Vol. 7_2025
Factors and mechanism of development of infectious and non-infectious pharyngitis
- 16 October 2025
- Published by Bionika Media in Therapy
- Vol. 7_2025
Factors and mechanism of development of infectious and non-infectious pharyngitis
- 6 June 2025
- Published by Media Sphere Publishing Group in Russian Rhinology
- Vol. 33 (2)
Pathomorphology of chronic polypous purulent rhinosinusitis in cystic fibrosis in children
Cystic fibrosis (CF) is a systemic autosomal recessive hereditary condition that is caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Chronic rhinosinusitis, which is a source of infection of the underlying respiratory tract, is one of the main CF manifestations. Objective. To study the pathomorphological characteristics of the mucous membrane of the paranasal sinuses (PNSs) with polypoid changes in CF and compare them with nasal polyps in chronic rhinosinusitis with nasal polyps (CRSwNP) in children and adolescents without CF. Material and methods. The study included histological specimens obtained from 97 patients with a confirmed diagnosis of cystic fibrosis who underwent endoscopic endonasal sinus surgery. The control group consisted of 29 patients with CRSwNP without CF. Results. It has been established that intraepithelial microabscesses, intraepithelial microcysts and gland cysts were significantly more often detected in patients with CF compared to the subjects with CRSwNP. Patients with CF are characterized by lower eosinophil-neutrophil ratio (ENR) rates compared to subjects with CRSwNP. There has been no relationship between genotype and pathomorphological characteristics of the mucous membrane of the PNSs in CF. Conclusion. The presence of intraepithelial microabscesses, intraepithelial microcysts and gland cysts can be considered as a pathomorphological marker of CF. Identification of these histological features in combination with a low value of the ENR will allow to suspect CF in patients with CRSwNP. Low ENR rates in patients with CF were suggestive of intranasal glucocorticosteroids’ insufficient effectiveness in the treatment of patients with this disease.
- 6 June 2025
- Published by Media Sphere Publishing Group in Russian Rhinology
- Vol. 33 (2)
Pathomorphology of chronic polypous purulent rhinosinusitis in cystic fibrosis in children
Cystic fibrosis (CF) is a systemic autosomal recessive hereditary condition that is caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Chronic rhinosinusitis, which is a source of infection of the underlying respiratory tract, is one of the main CF manifestations. Objective. To study the pathomorphological characteristics of the mucous membrane of the paranasal sinuses (PNSs) with polypoid changes in CF and compare them with nasal polyps in chronic rhinosinusitis with nasal polyps (CRSwNP) in children and adolescents without CF. Material and methods. The study included histological specimens obtained from 97 patients with a confirmed diagnosis of cystic fibrosis who underwent endoscopic endonasal sinus surgery. The control group consisted of 29 patients with CRSwNP without CF. Results. It has been established that intraepithelial microabscesses, intraepithelial microcysts and gland cysts were significantly more often detected in patients with CF compared to the subjects with CRSwNP. Patients with CF are characterized by lower eosinophil-neutrophil ratio (ENR) rates compared to subjects with CRSwNP. There has been no relationship between genotype and pathomorphological characteristics of the mucous membrane of the PNSs in CF. Conclusion. The presence of intraepithelial microabscesses, intraepithelial microcysts and gland cysts can be considered as a pathomorphological marker of CF. Identification of these histological features in combination with a low value of the ENR will allow to suspect CF in patients with CRSwNP. Low ENR rates in patients with CF were suggestive of intranasal glucocorticosteroids’ insufficient effectiveness in the treatment of patients with this disease.
- 30 October 2024
- Published by Bionika Media in Therapy
- Vol. 8_2024
Analysis of antibacterial drugs prescriptions for adult patients with acute and chronic rhinosinusitis during outpatient treatment in the Russian Federation
- 30 October 2024
- Published by Bionika Media in Therapy
- Vol. 8_2024
Analysis of antibacterial drugs prescriptions for adult patients with acute and chronic rhinosinusitis during outpatient treatment in the Russian Federation
- 30 September 2024
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- Vol. 87 (3) , 57-62
Methodology for determining the medical determinant of public health with the identification of medical risk factors for health disorders in otorhinolaryngology (on the example of analyzing the treatment of polyposis rhinosinusitis)
An algorithm for assessing the professional potential of an otorhinolaryngologic based on the identification of medical risk factors in the provision of medical care to patients with rhinosinusitis has been developed. A total of 627 otorhinolaryngologic from 32 subjects of the Russian Federation were screened and the treatment of patients with polyposis rhinosinusitis was analyzed. The proposed methodological approach was successfully used to assess the knowledge and skills of physicians of other specialties and formed the basis for the methodology of studying the professional potential of physicians, for which the author's invention certificates were also obtained. Keywords: public health, medical determinant of public health, medical personnel, human potential, professional potential, staff potential, medical risks, quality, interaction efficiency, medical effectiveness, polyposis rhinosinusitis, antibiotics, topical glucocorticosteroids, antiseptics, otorhinolaryngologic, sociological research.
- 30 September 2024
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- Vol. 87 (3) , 57-62
Methodology for determining the medical determinant of public health with the identification of medical risk factors for health disorders in otorhinolaryngology (on the example of analyzing the treatment of polyposis rhinosinusitis)
An algorithm for assessing the professional potential of an otorhinolaryngologic based on the identification of medical risk factors in the provision of medical care to patients with rhinosinusitis has been developed. A total of 627 otorhinolaryngologic from 32 subjects of the Russian Federation were screened and the treatment of patients with polyposis rhinosinusitis was analyzed. The proposed methodological approach was successfully used to assess the knowledge and skills of physicians of other specialties and formed the basis for the methodology of studying the professional potential of physicians, for which the author's invention certificates were also obtained. Keywords: public health, medical determinant of public health, medical personnel, human potential, professional potential, staff potential, medical risks, quality, interaction efficiency, medical effectiveness, polyposis rhinosinusitis, antibiotics, topical glucocorticosteroids, antiseptics, otorhinolaryngologic, sociological research.
- 4 September 2024
- Published by Bionika Media in Therapy
- Vol. 6_2024
Causes of pain syndrome in case of oropharynx inflammatory diseases
- 4 September 2024
- Published by Bionika Media in Therapy
- Vol. 6_2024
Causes of pain syndrome in case of oropharynx inflammatory diseases
- Open Access
- 6 June 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 9,p. 168-176
Incidence of coronavirus disease (COVID-19) in patients with different degrees of chronic rhinosinusitis with nasal polyps
Introduction. Chronic rhinosinusitis with nasal polyps (CRSwNP) pathogenesis is based on inadequate local immune response, additional SARS-CoV-2 infection can alter CRSwNP pathological process.Aim. To effect of COVID-19 on CRSwNP course in patients with different drug control degree.Materials and methods. 99 patients with bilateral CRSwNP (48 men, 51 women, 58.37 ± 14.43 years), were divided into 3 groups based on CRSwNP medical control degree for 5 years [17]. Group 1 (n = 34) – patients with mild CRSwNP received treatment according to treatment algorithm stages I and II. Group 2 (n = 32) – moderate severity CRSwNP, therapy corresponded to algorithm stage II or III. Group 3 (n = 33) – patients with severe CRSwNP received stage IV treatment 1 or more times. All data about vaccination against coronavirus infection and confirmed COVID-19 episodes with an analysis of its severity were recorded,Results. 63 people had COVID-19 (63.64%, 62.5 ± 13.1 years), of which 62.5% people were vaccinated before infection. COVID-19 was mild in 84.1% (54.70 ± 13.83 years), moderate COVID-19 – in 12.7% (63.1 ± 15.38 years), and severe – in 3.2% (age – 40 years). 36% people (62.5 ± 13.1 years) did not infected with coronavirus. In group 1 mild COVID-19 was observed in 35.29%, moderate severity – in 5.88%. In group 2 all patients who had COVID-19 (87.5%) had mild course. In group 3 39.39% patients had mild COVID-19, 18.18% had moderate COVID-19. Severe COVID-19 was observed in 2 people from this group.Conclusions. COVID-19 was mild in most cases in CRSwNP patients. In 84.1% patients were treated as outpatients. CRSwNP patients had frequent swabs to detect SARS-CoV-2 RNA due to complaints of hyposmia and raised coronavirus infection suspicion.
- 6 June 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 9,p. 168-176
Open AccessIncidence of coronavirus disease (COVID-19) in patients with different degrees of chronic rhinosinusitis with nasal polyps
Introduction. Chronic rhinosinusitis with nasal polyps (CRSwNP) pathogenesis is based on inadequate local immune response, additional SARS-CoV-2 infection can alter CRSwNP pathological process.Aim. To effect of COVID-19 on CRSwNP course in patients with different drug control degree.Materials and methods. 99 patients with bilateral CRSwNP (48 men, 51 women, 58.37 ± 14.43 years), were divided into 3 groups based on CRSwNP medical control degree for 5 years [17]. Group 1 (n = 34) – patients with mild CRSwNP received treatment according to treatment algorithm stages I and II. Group 2 (n = 32) – moderate severity CRSwNP, therapy corresponded to algorithm stage II or III. Group 3 (n = 33) – patients with severe CRSwNP received stage IV treatment 1 or more times. All data about vaccination against coronavirus infection and confirmed COVID-19 episodes with an analysis of its severity were recorded,Results. 63 people had COVID-19 (63.64%, 62.5 ± 13.1 years), of which 62.5% people were vaccinated before infection. COVID-19 was mild in 84.1% (54.70 ± 13.83 years), moderate COVID-19 – in 12.7% (63.1 ± 15.38 years), and severe – in 3.2% (age – 40 years). 36% people (62.5 ± 13.1 years) did not infected with coronavirus. In group 1 mild COVID-19 was observed in 35.29%, moderate severity – in 5.88%. In group 2 all patients who had COVID-19 (87.5%) had mild course. In group 3 39.39% patients had mild COVID-19, 18.18% had moderate COVID-19. Severe COVID-19 was observed in 2 people from this group.Conclusions. COVID-19 was mild in most cases in CRSwNP patients. In 84.1% patients were treated as outpatients. CRSwNP patients had frequent swabs to detect SARS-CoV-2 RNA due to complaints of hyposmia and raised coronavirus infection suspicion.
- 20 March 2024
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 89 (1) , 64-72
Acute and chronic rhinosinusitis age characteristics
Children’s and adults’ rhinosinusitis are two diseases that have both similarities and differences in anatomy, epidemiology, causes, pathogenesis, diagnosis and treatment. At the same rhinosinusitis is one of the most common in otorhinolaryngology’s practice, both in children and adults. The of adults paranasal sinuses (PNS) anatomy differs from children’s PNS anatomy. Although ostiomeatal complex occlusion is recognized as a major cause of poor ventilation and drainage of the adult paranasal sinuses, it does not have a strong effect on pediatric rhinosinusitis, but adenoids play a key role. Adenoids are bacteria and biofilms reservoirs that cause chronic refractory rhinosinusitis regardless of pharyngeal tonsil size. The prevalence of chronic rhinosinusitis (CRS) is lower in children than in adults. Diagnosis of children’s rhinosinusitis is more difficult because nasal cavity endoscopic examination is performed rarely due to the occasional need of general anesthesia during the procedure. Moreover, it’s necessary to take into account prevailing etiological role of viruses in ARS at children’s age and chronic adenoiditis often accompanies pediatric CRS, which requires attention prescribing medical therapy as the basis of rhinosinusitis treatment. The DysheLORz based on Pelargonium sidoides roots is highly effective and safe for children’s and adults ARS and CRS treatment, both as monotherapy and in combination with topical steroids and antibiotics. This herbal medicine immunomodulatory effect is mediated mainly by stimulating the production of TNF-α, IL-1, IL-12 and IFN-γ. It activates macrophages and improves their phagocytic activity. IL-12, together with TNF-α, enhances NK and cytotoxic CD8+ lymphocytes’ activity against infected cells. IL-12 effect on Th1 lymphocytes maturation provides a link between innate and adaptive immunity. This is also increasing MCP-1, IP-10 and MIP-1β chemokines synthesis and decreasing MIP-1α, ENA-78, GROα and IL-8 production in PNS and nasal mucosa. This leads to decrease of neutrophils chemotaxis to the inflammation site, and decline of serine proteases concentration (neutrophils main enzymes), that increases mucous membrane epithelial barrier permeability, reducing bacterial infections risk. Additionally, Pelargonium sidoides increases epithelial cells beating cilia frequency and inhibits hemagglutinin and neuraminidase present on influenza virus surface. The drug increases antimicrobial peptides production as defensins, human neutrophil peptides (HNP) and bactericidal permeability-increasing protein (BPI), which is also important for rapid inflammation regression in rhinosinusitis. It causes bacterial adhesion to epithelial cells inhibition, phagocytosis stimulation, nitric oxide (NO) release and oxidative burst. The medicine had a direct effect on Streptococcus pneumoniae, Staphylococcus aureus, Neisseria, Moraxella catarrhalis and Haemophilus influenza. Based on these data, it is possible to explain the high effectiveness and safety of the drugs based on Pelargonium sidoides in ENT organs inflammation treatment, for both adults and children over 1 year old.
- 20 March 2024
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 89 (1) , 64-72
Acute and chronic rhinosinusitis age characteristics
Children’s and adults’ rhinosinusitis are two diseases that have both similarities and differences in anatomy, epidemiology, causes, pathogenesis, diagnosis and treatment. At the same rhinosinusitis is one of the most common in otorhinolaryngology’s practice, both in children and adults. The of adults paranasal sinuses (PNS) anatomy differs from children’s PNS anatomy. Although ostiomeatal complex occlusion is recognized as a major cause of poor ventilation and drainage of the adult paranasal sinuses, it does not have a strong effect on pediatric rhinosinusitis, but adenoids play a key role. Adenoids are bacteria and biofilms reservoirs that cause chronic refractory rhinosinusitis regardless of pharyngeal tonsil size. The prevalence of chronic rhinosinusitis (CRS) is lower in children than in adults. Diagnosis of children’s rhinosinusitis is more difficult because nasal cavity endoscopic examination is performed rarely due to the occasional need of general anesthesia during the procedure. Moreover, it’s necessary to take into account prevailing etiological role of viruses in ARS at children’s age and chronic adenoiditis often accompanies pediatric CRS, which requires attention prescribing medical therapy as the basis of rhinosinusitis treatment. The DysheLORz based on Pelargonium sidoides roots is highly effective and safe for children’s and adults ARS and CRS treatment, both as monotherapy and in combination with topical steroids and antibiotics. This herbal medicine immunomodulatory effect is mediated mainly by stimulating the production of TNF-α, IL-1, IL-12 and IFN-γ. It activates macrophages and improves their phagocytic activity. IL-12, together with TNF-α, enhances NK and cytotoxic CD8+ lymphocytes’ activity against infected cells. IL-12 effect on Th1 lymphocytes maturation provides a link between innate and adaptive immunity. This is also increasing MCP-1, IP-10 and MIP-1β chemokines synthesis and decreasing MIP-1α, ENA-78, GROα and IL-8 production in PNS and nasal mucosa. This leads to decrease of neutrophils chemotaxis to the inflammation site, and decline of serine proteases concentration (neutrophils main enzymes), that increases mucous membrane epithelial barrier permeability, reducing bacterial infections risk. Additionally, Pelargonium sidoides increases epithelial cells beating cilia frequency and inhibits hemagglutinin and neuraminidase present on influenza virus surface. The drug increases antimicrobial peptides production as defensins, human neutrophil peptides (HNP) and bactericidal permeability-increasing protein (BPI), which is also important for rapid inflammation regression in rhinosinusitis. It causes bacterial adhesion to epithelial cells inhibition, phagocytosis stimulation, nitric oxide (NO) release and oxidative burst. The medicine had a direct effect on Streptococcus pneumoniae, Staphylococcus aureus, Neisseria, Moraxella catarrhalis and Haemophilus influenza. Based on these data, it is possible to explain the high effectiveness and safety of the drugs based on Pelargonium sidoides in ENT organs inflammation treatment, for both adults and children over 1 year old.